Search Results

A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial.

• Authors : Schwalm, Jon-David¹ (AUTHOR) ; McCready, Tara¹ (AUTHOR); Lopez-Jaramillo, Patricio^2,3 (AUTHOR)

Subjects: *RESEARCH; CARDIOVASCULAR diseases risk factors; SYSTOLIC blood pressureCOLOMBIA; ONTARIO; MALAYSIABOEHRINGER Ingelheim GmbH

• Source: Lancet. Oct2019, Vol. 394 Issue 10205, p1231-1242. 12p.

Record details

GSK and Boehringer agree to generic AIDS drugs deal.

• Source: Lancet. 12/20/2003, Vol. 362 Issue 9401, p2074-2074. 1p. 1 Black and White Photograph.

Record details

Questions about authorisation of alteplase for ischaemic stroke.

• Authors : Sandercock, Peter¹ ; Lindley, Richard²; Wardlaw, Joanna M.¹

Subjects: *STROKE treatment; *TISSUE plasminogen activator; *CLINICAL drug trialsNATIONAL Institute of Neurological Disorders & Stroke (U.S.) ; BOEHRINGER Ingelheim GmbH

• Source: Lancet. 8/23/2014, Vol. 384 Issue 9944, p660-661. 2p.

Record details